patrick.net

The BBC looks at the ‘Why Covid is Still Flooring Some People’.

Wait a minute, I thought Covid vaccines were not only supposed to stop people from getting Covid but if they were one of the very, very rare cases that did, supposed to stop them from getting ill?

I guess the BBC must be talking about unvaccinated people getting Covid at the moment? But every unvaccinated person that I know isn’t continually getting reinfected. And if they are, they certainly don’t know about it.

And we can all remember, only last year, how much the BBC liked to belittle the unvaccinated. They reported on unvaccinated people dying and made programmes to make the unvaccinated look like insane, social pariahs. So if this current article was referring to unvaccinated people you can bet your bottom dollar that it would be in the headline, as well as repeated multiple times every sentence.

But the article doesn’t use the word ‘unvaccinated’ once, so we can only assume that the case studies are vaccinated people.

Yawn. So far we have an unremarkable covid variant, disinterested corporate media, and below-average (albeit increasing) hospitalization levels. So what gives? What’s stirring up all the natives down at the Fauci Memorial Reservation this time?

Two data fuel all the delirious trepidation. First, the vaccines are completely useless against the heavily-mutated Pirola variant (that is, if they ever accomplished anything in the first place). More relevant, for some reason people without fully functioning immune systems lack good biological defenses to the new variant. But nobody’s really talking about this issue, as you can imagine.

More discussed is the second fact fueling the social media chatter: the rate of increase of JN.1 hospitalizations. It’s really the only JN.1 figure worth mentioning. Reported hospitalizations are low but rising rapidly, or “surging.” ...

In the clip, to prove he is right, Geert asked himself several apocalyptic questions and then provided his own answers:

Will the chain of more and more infectious variants ever stop? Yes. We will not have yet another simply more infectious variant that will displace JN.1.

Will a completely new, highly-virulent variant emerge in highly-vaccinated countries? Yes.

Will the rate of mortality and morbidity start to exponentially increase? Yes — but only in the vaccinated. It will be difficult to get these figures though.

Will Unvaccinated or people in low-uptake Africa be affected? No.

... I can’t argue with Geert’s science. Literally I couldn’t argue with him. He’s way out of my scientific league. But I do not yet see the evidence for his theory. From day one I asked public health officials about antibody-dependent enhancement and immune escape and never once got any intelligent answer, not one time. I’ve since learned why. Most public health officials don’t understand vaccine science; they’re just good liars who can repeat whatever they’re told in a strong, confident tone of voice.

Their smug, arrogant condescension toward anyone who questions them is just an act. Scientists didn’t refuse to answer questions because they actually believed they’re better than us and didn’t want to sully themselves with “conspiracy theories.” The real reason is that, if they started trying to answer questions, it would have quickly become obvious they had no idea what they’re talking about.

Geert knows what he’s talking about. I’d take Geert over a CDC official any day. And his predictions have been right before. Geert was 100% right with his prediction that mass vaccination would drive evolution of a large number of immune escape variants.

The plain evidence shows an unusual number of major covid mutations all trending toward evading vaccine coverage. ...

Geert might be right. And it’s not like we have a lot of options for who to believe. Even with fabulously-expensive satellite-mounted telescopes, no intelligent thought can be detected at the government-funded health agencies. But Geert’s theory depends on a new, as-yet-unseen variant that would violate evolutionary norms.

See, viruses are under constant pressure to mutate to be less virulent and more transmissible, which is exactly what we’ve seen with Pirola and prior covid variants. A virus that kills people or keeps them in bed does not survive better than a milder virus that lets folks move around and spread the germ.

The bottom line? So far, Pirola Junior appears to be yet another milder, ever-more-infectious covid variant. But I’ll keep an eye on things for you and let you know immediately if any evidence supporting Geert’s prediction evolves. Till then, don’t take your medical advice from Eric Fingle-de-Dee, MD.

EU countries destroy €4B worth of COVID vaccines

Howard Stern gets Covid

And we’re the morons, imbeciles and idiots. ...

As reported by PennLive.com and other news organizations, "Stern revealed to fans during his Monday show that he was off the air last week because he had come down with the virus.”

“I just want to announce something,” Stern said after noting he was off last week. COVID is really bad. You do not want COVID. Oh (expletive). Man, I went through hell … I’ve never really been this sick,” he added.

Stern, it goes without writing, was quick to thank the makers of the COVID-19 vaccine.

“…. I must thank the scientist who developed the COVID vaccine.’

“What a wallop this thing is … can you imagine if we didn’t have a vaccine?” he said.

Despite constantly wearing masks and receiving up to eight vaccines or boosters, somehow Stern still gave COVID-19 to his wife, Beth Stern, who one assumes is also fully-vaccinated (or Stern would have surely divorced her by now).

https://brownstone.org/articles/16-studies-on-vaccine-efficacy/

Example of studies below:

1) Gazit et alshowed that “SARS-CoV-2-naïve vaccinees had a 13-fold (95% CI, 8-21) increased risk for breakthrough infection with the Delta variant compared to those previously infected.” When adjusting for the time of disease/vaccine, there was a 27-fold increased risk (95% CI, 13-57).

2) Acharya et al.Ignoring the risk of infection, given that someone was infected, Acharya et al. found “no significant difference in cycle threshold values between vaccinated and unvaccinated, asymptomatic and symptomatic groups infected with SARS-CoV-2 Delta.”

3) Riemersma et al.found “no difference in viral loads when comparing unvaccinated individuals to those who have vaccine “breakthrough” infections. Furthermore, individuals with vaccine breakthrough infections frequently test positive with viral loads consistent with the ability to shed infectious viruses.” Results indicate that “if vaccinated individuals become infected with the delta variant, they may be sources of SARS-CoV-2 transmission to others.” They reported “low Ct values (<25) in 212 of 310 fully vaccinated (68%) and 246 of 389 (63%) unvaccinated individuals. Testing a subset of these low-Ct samples revealed infectious SARS-CoV-2 in 15 of 17 specimens (88%) from unvaccinated individuals and 37 of 39 (95%) from vaccinated people.”

4) Chemaitelly et al.In a study from Qatar, Chemaitelly et al. reported vaccine efficacy (Pfizer) against severe and fatal disease, with efficacy in the 85-95% range at least until 24 weeks after the second dose. As a contrast, the efficacy against infection waned down to around 30% at 15-19 weeks after the second dose.

5) Riemersma et al.From Wisconsin, Riemersma et al. reported that vaccinated individuals who get infected with the Delta variant can transmit SARS-CoV-2 to others. They found an elevated viral load in the unvaccinated and vaccinated symptomatic persons (68% and 69% respectively, 158/232 and 156/225). Moreover, in the asymptomatic persons, they uncovered elevated viral loads (29% and 82% respectively) in the unvaccinated and the vaccinated respectively. This suggests that the vaccinated can be infected, harbor, cultivate, and transmit the virus readily and unknowingly.

6) SubramanianSubramanian reported that “at the country-level, there appears to be no discernable relationship between percentage of population fully vaccinated and new COVID-19 cases.” When comparing 2947 counties in the United States, there were slightly less cases in more vaccinated locations. In other words, there is no clear discernable relationship .

7) Chau et al.looked at transmission of SARS-CoV-2 Delta variant among vaccinated healthcare workers in Vietnams. Of 69 healthcare workers that tested positive for SARS-CoV-2, 62 participated in the clinical study, all of whom recovered. For 23 of them, complete-genome sequences were obtained, and all belonged to the Delta variant. “Viral loads of breakthrough Delta variant infection cases were 251 times higher than those of cases infected with old strains detected between March-April 2020”.

8) Brown et al.In Barnstable, Massachusetts, Brown et al. found that among 469 cases of COVID-19, 74% were fully vaccinated, and that “the vaccinated had on average more virus in their nose than the unvaccinated who were infected.”

9) Hetemäli et al.Reporting on a nosocomial hospital outbreak in Finland, Hetemäli et al. observed that “both symptomatic and asymptomatic infections were found among vaccinated health care workers, and secondary transmission occurred from those with symptomatic infections despite use of personal protective equipment.”

10) Shitrit et al.In a hospital outbreak investigation in Israel, Shitrit et al. observed “high transmissibility of the SARS-CoV-2 Delta variant among twice vaccinated and masked individuals.” They added that “this suggests some waning of immunity, albeit still providing protection for individuals without comorbidities.”

11) UK COVID-19 vaccine Surveillance Report for week #42In the UK COVID-19 vaccine Surveillance Report for week #42, it was noted that there is “waning of the N antibody response over time” and “that N antibody levels appear to be lower in individuals who acquire infection following 2 doses of vaccination.” The same report (Table 2, page 13), shows the in the older age groups above 30, the double vaccinated persons have greater infection risk than the unvaccinated, presumably because the latter group include more people with stronger natural immunity from prior Covid disease. As a contrast, the vaccinated people had a lower risk of death than the unvaccinated, across all age groups, indicating that vaccines provide more protection against death than against infection. See also UK PHE reports 43, 44, 45, 46 for similar data.

12) Levin et al.In Israel, Levin et al. “conducted a 6-month longitudinal prospective study involving vaccinated health care workers who were tested monthly for the presence of anti-spike IgG and neutralizing antibodies”. They found that “six months after receipt of the second dose of the BNT162b2 vaccine, humoral response was substantially decreased, especially among men, among persons 65 years of age or older, and among persons with immunosuppression.”

13) Rosenberg et al.In a study from New York State, Rosenberg et al. reported that “During May 3–July 25, 2021, the overall age-adjusted vaccine effectiveness against hospitalization in New York was relatively stable 89.5%–95.1%). The overall age-adjusted vaccine effectiveness against infection for all New York adults declined from 91.8% to 75.0%.”

14) Suthar et al.Suthar et al. noted that “Our data demonstrate a substantial waning of antibody responses and T cell immunity to SARS-CoV-2 and its variants, at 6 months following the second immunization with the BNT162b2 vaccine.”

15) Nordström et al.In a study from Umeå University in Sweden, Nordström et al. observed that “vaccine effectiveness of BNT162b2 against infection waned progressively from 92% (95% CI, 92-93, P<0·001) at day 15-30 to 47% (95% CI, 39-55, P<0·001) at day 121-180, and from day 211 and onwards no effectiveness could be detected (23%; 95% CI, -2-41, P=0·07).”

16) Yahi et al.Yahi et al. have reported that “in the case of the Delta variant, neutralizing antibodies have a decreased affinity for the spike protein, whereas facilitating antibodies display a strikingly increased affinity. Thus, antibody dependent enhancement may be a concern for people receiving vaccines based on the original Wuhan strain spike sequence.”

17) Goldberg et al. (BNT162b2 Vaccine in Israel) reported that “immunity against the delta variant of SARS-CoV-2 waned in all age groups a few months after receipt of the second dose of vaccine.”

18) Singanayagam et al.examined the transmission and viral load kinetics in vaccinated and unvaccinated individuals with mild delta variant infection in the community. They found that (in 602 community contacts (identified via the UK contract-tracing system) of 471 UK COVID-19 index cases were recruited to the Assessment of Transmission and Contagiousness of COVID-19 in Contacts cohort study and contributed 8145 upper respiratory tract samples from daily sampling for up to 20 days) “vaccination reduces the risk of delta variant infection and accelerates viral clearance. Nonetheless, fully vaccinated individuals with breakthrough infections have peak viral load similar to unvaccinated cases and can efficiently transmit infection in household settings, including to fully vaccinated contacts.”

19) Keehner et al.in NEJM, has recently reported on the resurgence of SARS-CoV-2 infection in a highly vaccinated health system workforce. Vaccination with mRNA vaccines began in mid-December 2020; by March, 76% of the workforce had been fully vaccinated, and by July, the percentage had risen to 87%. Infections had decreased dramatically by early February 2021…”coincident with the end of California’s mask mandate on June 15 and the rapid dominance of the B.1.617.2 (delta) variant that first emerged in mid-April and accounted for over 95% of UCSDH isolates by the end of July, infections increased rapidly, including cases among fully vaccinated persons…researchers reported that the “dramatic change in vaccine effectiveness from June to July is likely to be due to both the emergence of the delta variant and waning immunity over time.”

...

Fager

In July of 2021, The Lancet produced a study that included absolute risk reduction figures for the various jabs. The BioNtech relative risk reduction was publicly claimed to be 95.03%; the absolute risk reduction was .84%--and for obvious reasons that one was never reported by the pushers of the jabs. Moderna was 94.08% vs. 1.24%; Janssen was 66.62% vs. 1.19%; and AstraZeneca was 66.84% vs. 1.28%.

The once and future pharma employees at the FDA know damned well that to meaningfully evaluate a drug's benefits, one needs to know both relative and absolute risk reduction. It knows damned well that leaving ARR out of what's reported to doctors and patients is completely misleading; it knows damned well that most doctors don't notice the absence or ascribe any importance to that absence. Yet, impelled by even a little skepticism about the TrueNarrative™, in 2021 even a layman could find that information, understand its significance, and realize the implications of it being deliberately omitted from all the wonder-drug headlines.